PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsIrinotecan hydrochloride
Irinotecan hydrochloride
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
1891 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Colorectal neoplasmsD0151791544501231162713
NeoplasmsD009369C8019111226112294
AdenocarcinomaD0002306113329112211
Stomach neoplasmsD013274EFO_0003897C1632802249134
Neoplasm metastasisD009362EFO_0009708195727316113
Rectal neoplasmsD012004216318110104
Lung neoplasmsD008175HP_0100526C34.9029711124102
Esophageal neoplasmsD004938C151655131583
Colonic neoplasmsD003110C182543171882
Small cell lung carcinomaD0557522249112575
Show 7 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Pancreatic neoplasmsD010190EFO_0003860C25881733620274
CarcinomaD002277C80.03471203113
RecurrenceD01200828379367
Pancreatic ductal carcinomaD02144117295348
SarcomaD01250921264347
GlioblastomaD005909EFO_00005152127343
Breast neoplasmsD001943EFO_0003869C5013231439
RhabdomyosarcomaD01220815184130
Squamous cell carcinomaD002294719730
Esophageal squamous cell carcinomaD000077277619830
Show 53 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Non-small-cell lung carcinomaD0022892135248
GliomaD005910EFO_0000520202539
Central nervous system neoplasmsD0165431714127
Nervous system neoplasmsD009423151424
Ovarian neoplasmsD010051EFO_0003893C561112120
Triple negative breast neoplasmsD06472610815
LymphomaD008223C85.910414
AstrocytomaD001254EFO_00002718713
Ovarian epithelial carcinomaD0000772167511
GliosarcomaD0183166611
Show 92 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Gastrointestinal stromal tumorsD046152EFO_0000505C49.A55
Precursor cell lymphoblastic leukemia-lymphomaD054198314
Prostatic neoplasmsD011471C6133
Hodgkin diseaseD006689C8133
Large b-cell lymphoma diffuseD016403C83.333
Acute diseaseD000208112
B-cell chronic lymphocytic leukemiaD015451C91.122
ChondrosarcomaD00281322
Malignant mesotheliomaD00008600222
Burkitt lymphomaD002051C83.722
Show 45 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PrognosisD01137922
Lymphoid leukemiaD007945C9111
Body weightD001835EFO_000433811
Weight lossD015431HP_000182411
HypertensionD006973EFO_0000537I1011
ChemoradiotherapyD05924811
Brain deathD001926G93.8211
MucositisD052016EFO_100189811
Male breast neoplasmsD01856711
Ultrasonic therapyD01446411
Show 3 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 1,228 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use